Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 1

Drug reimportation practices in the United States

Authors Monali J Bhosle, Rajesh Balkrishnan

Published 15 March 2007 Volume 2007:3(1) Pages 41—46

Monali J Bhosle, Rajesh Balkrishnan

Department of Pharmacy Practice and Administration, Ohio State University, Columbus, OH, USA

Background: Drug reimportation is perceived as a costs-cutting strategy by Americans. Nonetheless, issues such as drug safety and efficacy prevent legalization of the practice. With the contradictory views from supporters and opponents, debate on drug reimportation continues to snowball. The objective of this commentary is to discuss issues regarding drug reimportation practices in the United States (US). It also examines policy implications and potential solutions of the controversy.

Findings: Comparatively inexpensive drugs available across the border help Americans relieve the burden of medication costs. Consequently, the volume of reimported drugs entering the US has considerably increased. However, these practices are illegal and legalization of drug reimportation is a political debate. While safety is the most important barrier for legalization, this concern does not seem to affect growing number of Americans who are getting their prescriptions filled from across the border. Canadians oppose legalization of reimportation in the US as it could exacerbate the problem of medication shortage in Canada.

Summary: Currently, legalization of dug reimportation has wedged between the arguments by different groups. Until the US government finds a solution to reduce medication costs, it seems to be impossible to stop Americans from buying the comparatively inexpensive medications available across the border.

Keywords: drug reimportation, drug importation, prescription drug costs, drugs from Canada

Download Article [PDF] 

Readers of this article also read:

Simvastatin enhances Rho/actin/cell rigidity pathway contributing to mesenchymal stem cells’ osteogenic differentiation

Tai IC, Wang YH, Chen CH, Chuang SC, Chang JK, Ho ML

International Journal of Nanomedicine 2015, 10:5881-5894

Published Date: 21 September 2015

Caenorhabditis elegans as an alternative in vivo model to determine oral uptake, nanotoxicity, and efficacy of melatonin-loaded lipid-core nanocapsules on paraquat damage

Charão MF, Souto C, Brucker N, Barth A, Jornada DS, Fagundez D, Ávila DS, Eifler-Lima VL, Guterres SS, Pohlmann AR, Garcia SC

International Journal of Nanomedicine 2015, 10:5093-5106

Published Date: 10 August 2015

Early enteral and parenteral nutritional support after hepatectomy in patients with hepatic carcinoma: a systematic review and meta-analysis

Gao LB, Tian H, Wang XG, Yu XF, Guan Y, Chen ML, Zhang J

OncoTargets and Therapy 2015, 8:623-631

Published Date: 10 March 2015

Enhanced transdermal bioavailability of testosterone propionate via surfactant-modified ethosomes

Meng S, Chen Z, Yang L, Zhang W, Liu D, Guo J, Guan Y, Li J

International Journal of Nanomedicine 2013, 8:3051-3060

Published Date: 13 August 2013

Paclitaxel-Fe3O4 nanoparticles inhibit growth of CD138–  CD34– tumor stem-like cells in multiple myeloma-bearing mice

Yang C, Wang J, Chen D, Chen J, Xiong F, Zhang H, Zhang Y, Gu N, Dou J

International Journal of Nanomedicine 2013, 8:1439-1449

Published Date: 12 April 2013

Novel nanostructured biomaterials: implications for coronary stent thrombosis

Karagkiozaki V, Karagiannidis PG, Kalfagiannis N, Kavatzikidou P, Patsalas P, Georgiou D, Logothetidis S

International Journal of Nanomedicine 2012, 7:6063-6076

Published Date: 17 December 2012

Oriental oculopalpebral dimensions: Quantitative comparison between Orientals from Japan and Brazil

Rodrigo U Takahagi, Silvana A Schellini, Carlos R Padovani, Shinji Ideta, Nobutada Katori, Yasuhisa Nakamura

Clinical Ophthalmology 2008, 2:563-567

Published Date: 12 September 2008